Benzinga's Top Pre-Market Gainers
Targacept (NASDAQ: TRGT) soared 5.34% to $4.54 in the pre-market trading. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder.
VIVUS (NASDAQ: VVUS) surged 3.58% to $23.75 in the pre-market session. VIVUS announced the US market availability of Qsymia™.
Vodafone Group Public Limited Company (NASDAQ: VOD) added 1.42% to $28.65 in the pre-market session. Vodafone has a dividend yield of 7%.
ARM Holdings plc (NASDAQ: ARMH) moved up 0.98% to $28.79 in the pre-market session. ARM Holdings' trailing-twelve-month operating margin is 36.82%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.